Contribution: Industrial Research Assistance Program – Contributions to Firms
Reformulary Group Inc.
$50,000.00
Business Development project for creation of Cannabis Standard Formulary
FY 2018-19 · 2018-09-03
Summary
Cannabis Standard will be an evidence-based medical cannabis formulary based on best available evidence and expert advice. Cannabis Standard includes the formulary with detailed specifications, digital platform that produces the ACMPR-required Medical Document, and registry to capture real-world patient outcomes (quality of life and productivity data).
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
819455601
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2019-02-28
Agreement Number
914180
Agreement Start Date
2018-09-03
Agreement Title
Business Development project for creation of Cannabis Standard Formulary
Agreement Title (French)
Projet de développement commercial pour la création de Cannabis Standard Formulary
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Cannabis Standard will be an evidence-based medical cannabis formulary based on best available evidence and expert advice. Cannabis Standard includes the formulary with detailed specifications, digital platform that produces the ACMPR-required Medical Document, and registry to capture real-world patient outcomes (quality of life and productivity data).
Description (French)
Cannabis Standard sera un formulaire de cannabis médical fondé sur des preuves et basé sur les meilleures preuves disponibles et conseils d'experts. Cannabis Standard inclut le formulaire avec les spécifications détaillées, la plate-forme numérique, qui produit le document médical requis par ACMPR et un registre permettant de saisir les résultats réels des patients (données de qualité de vie et de productivité).
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Spadina--Fort York
Federal Riding (French)
Spadina--Fort York
Federal Riding Number
35101
NAICS Code
51121
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
819455601
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
Reformulary Group Inc.
Recipient Postal Code
M5J 1R7
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2018-2019-Q4-914180
